| Chapter 7 comments |
|
7.1 Agreements: A Review of Essential Tools of IP Management
|
4 |
Admin |
9 |
11/03/2010 11:53:20
Handbook Editors
|
| Chapter 6 comments |
|
6.6 Administration of a Large Technology Transfer Office
|
3 |
Admin |
6 |
11/03/2010 10:58:06
Handbook Editors
|
| Chapter 6 comments |
|
6.1 Ten Things Heads of Institutions Should Know about Setting Up a Technology Transfer Office
|
2 |
Admin |
115 |
11/03/2010 10:52:26
Handbook Editors
|
| Chapter 5 comments |
|
5.7 Conflict of Interest and Conflict of Commitment Management in Technology Transfer
|
2 |
Admin |
6 |
11/03/2010 10:47:35
Handbook Editors
|
| Chapter 5 comments |
|
5.6 Conducting IP Audits
|
4 |
Admin |
8 |
11/03/2010 10:43:45
Handbook Editors
|
| Chapter 5 comments |
|
5.5 The Role of the Inventor in the Technology Transfer Process
|
6 |
Admin |
10 |
11/03/2010 10:36:44
Handbook Editors
|
| Chapter 5 comments |
|
5.4 Ownership of University Inventions: Practical Considerations
|
5 |
Admin |
9 |
11/03/2010 10:29:13
Handbook Editors
|
| Chapter 5 comments |
|
5.3 Making the Most of Intellectual Property: Developing an Institutional IP Policy
|
6 |
Admin |
9 |
11/03/2010 10:19:37
Handbook Editors
|
| Chapter 5 comments |
|
5.2 IP Management Policy: A Donor's Perspective
|
4 |
Admin |
10 |
11/03/2010 10:09:22
Handbook Editors
|
| Chapter 5 comments |
|
5.1 IP Strategy
|
4 |
Admin |
10 |
11/03/2010 09:58:54
Handbook Editors
|
| Chapter 10 comments |
|
10.6 A Guide to International Patent Protection
|
0 |
Admin |
3 |
10/03/2010 14:43:56
Admin
|
| Chapter 4 comments |
|
4.10 Regulatory Data Protection in Pharmaceuticals and Other Sectors
|
5 |
Admin |
9 |
10/03/2010 14:17:06
Handbook Editors
|
| Chapter 4 comments |
|
4.9 Data Protection and Data Exclusivity in Pharmaceuticals and Agrochemicals
|
5 |
Admin |
8 |
10/03/2010 14:11:52
Handbook Editors
|
| Chapter 4 comments |
|
4.8 IP and Information Management: Libraries, Databases, Geographic Information Systems, and Software
|
2 |
Admin |
6 |
10/03/2010 13:58:37
Handbook Editors
|
| Chapter 4 comments |
|
4.7 Plant Variety Protection, International Agricultural Research, and Exchange of Germplasm: Legal Aspects of Sui Generis and Patent Regimes
|
3 |
Admin |
143 |
10/03/2010 13:56:03
Handbook Editors
|
| Chapter 4 comments |
|
4.6 Plants, Germplasm, Genebanks, and Intellectual Property: Principles, Options, and Management
|
5 |
Admin |
8 |
10/03/2010 13:48:37
Handbook Editors
|
| Chapter 4 comments |
|
4.5 Plant Breeders' Rights: An Introduction
|
5 |
Admin |
9 |
10/03/2010 13:35:28
Handbook Editors
|
| Chapter 4 comments |
|
4.4 The Statutory Toolbox: Plants
|
1 |
Admin |
6 |
10/03/2010 13:13:02
Handbook Editors
|
| Chapter 10 comments |
|
10.9 The Interface of Patents with the Regulatory Drug Approval Process and How Resulting Interplay Can Affect Market Entry
|
0 |
Admin |
5 |
09/03/2010 22:46:54
Admin
|
| Chapter 4 comments |
|
4.3 Trademark Primer
|
2 |
Admin |
7 |
09/03/2010 04:46:35
Handbook Editors
|
| Chapter 4 comments |
|
4.2 How to Read a Biotech Patent
|
3 |
Admin |
127 |
09/03/2010 04:43:34
Handbook Editors
|
| Chapter 4 comments |
|
4.1 The Statutory Toolbox: An Introduction
|
4 |
Admin |
8 |
09/03/2010 04:25:56
Handbook Editors
|
| Chapter 3 comments |
|
3.14 Building Research Clusters: Exploring Public Policy Options for Supporting Regional Innovation
|
3 |
Admin |
6 |
09/03/2010 02:14:34
Handbook Editors
|
| Chapter 3 comments |
|
3.13 The Activities and Roles of M.I.T. in Forming Clusters and Strengthening Entrepreneurship
|
1 |
Admin |
65 |
09/03/2010 02:08:43
Handbook Editors
|
| Chapter 3 comments |
|
3.12 What Does It Take to Build a Local Biotechnology Cluster in a Small Country? The Case of Turku, Finland
|
4 |
Admin |
8 |
09/03/2010 02:05:26
Handbook Editors
|
| Chapter 3 comments |
|
3.11 The Role of Clusters in Driving Innovation
|
3 |
Admin |
6 |
09/03/2010 01:52:39
Handbook Editors
|
| Chapter 3 comments |
|
3.10 Compulsory Licensing: How to Gain Access to Patented Technology
|
3 |
Admin |
7 |
09/03/2010 01:44:31
Handbook Editors
|
| Chapter 3 comments |
|
3.9 U.S. Laws Affecting the Transfer of Intellectual Property
|
4 |
Admin |
8 |
09/03/2010 01:32:25
Handbook Editors
|
| Chapter 3 comments |
|
3.8 The TRIPS Agreement and Intellectual Property in Health and Agriculture
|
6 |
Admin |
11 |
09/03/2010 01:16:34
Handbook Editors
|
| Chapter 3 comments |
|
3.7 Developing Countries and TRIPS: What Next?
|
3 |
Admin |
9 |
09/03/2010 00:59:11
Handbook Editors
|
| Chapter 3 comments |
|
3.6 Public Sector IP Management in the Life Sciences: Reconciling Practice and Policy-Perspectives from WIPO
|
1 |
Admin |
4 |
09/03/2010 00:50:44
Handbook Editors
|
| Chapter 3 comments |
|
3.5 Benchmarking of Technology Transfer Offices and What It Means for Developing Countries
|
3 |
Admin |
6 |
09/03/2010 00:48:58
Handbook Editors
|
| Other comments |
|
ipHandbook of Best Practices: Ghana
|
0 |
Admin |
7 |
09/03/2010 00:44:28
Admin
|
| Chapter 3 comments |
|
3.4 Technology Transfer Snapshots from Middle-Income Countries: Creating Socio-Economic Benefits through Innovation
|
4 |
Admin |
7 |
09/03/2010 00:41:25
Handbook Editors
|
| Chapter 3 comments |
|
3.3 Echoes of Bayh-Dole? A Survey of IP and Technology Transfer Policies in Emerging and Developing Economies
|
2 |
Admin |
5 |
09/03/2010 00:32:57
Handbook Editors
|
| Chapter 3 comments |
|
3.1 The Courts and Innovation
|
4 |
Admin |
8 |
09/03/2010 00:28:27
Handbook Editors
|
| Chapter 12 comments |
|
12.4 IP Portfolio Management: Negotiating the Information Labyrinth
|
0 |
Admin |
4 |
08/03/2010 05:00:34
Admin
|
| Chapter 2 comments |
|
2.8 Facilitating Assembly of and Access to Intellectual Property: Focus on Patent Pools and a Review of Other Mechanisms
|
3 |
Admin |
8 |
07/03/2010 13:14:56
Handbook Editors
|
| Chapter 2 comments |
|
2.7 Using Milestones in Healthcare Product Licensing Deals to Ensure Access in Developing Countries
|
3 |
Admin |
8 |
07/03/2010 13:07:31
Handbook Editors
|
| Chapter 2 comments |
|
2.6 Open Source Licensing
|
2 |
Admin |
6 |
07/03/2010 13:04:20
Handbook Editors
|
| Chapter 2 comments |
|
2.5 Valuation and Licensing in Global Health
|
4 |
Admin |
8 |
07/03/2010 13:01:18
Handbook Editors
|
| Chapter 2 comments |
|
2.4 Patenting and Licensing Research Tools
|
3 |
Admin |
8 |
07/03/2010 12:49:05
Handbook Editors
|
| Chapter 2 comments |
|
2.3 Ensuring Global Access through Effective IP Management: Strategies of Product-Development Partnerships
|
3 |
Admin |
10 |
07/03/2010 12:40:24
Handbook Editors
|
| Chapter 2 comments |
|
2.2 Facilitating Humanitarian Access to Pharmaceutical and Agricultural Innovation
|
4 |
Admin |
8 |
07/03/2010 12:35:19
Handbook Editors
|
| Chapter 2 comments |
|
2.1 Reservation of Rights for Humanitarian Uses
|
4 |
Admin |
8 |
07/03/2010 12:25:24
Handbook Editors
|
| Chapter 1 comments |
|
1.5 Genomics, Ethics, and Intellectual Property
|
7 |
Admin |
14 |
07/03/2010 12:12:56
Handbook Editors
|
| Chapter 1 comments |
|
1.4 Ensuring Developing-Country Access to New Inventions: The Role of Patents and the Power of Public Sector Research Institutions
|
3 |
Admin |
7 |
07/03/2010 11:58:52
Handbook Editors
|
| Chapter 1 comments |
|
1.3 IP Management and Deal Making for Global Health Outcomes: The New 'Return on Imagination' (ROI)
|
6 |
Admin |
25 |
07/03/2010 11:42:46
Handbook Editors
|
| Chapter 1 comments |
|
1.2 Building Product Innovation Capability in Health
|
1 |
Admin |
21 |
02/03/2010 07:17:32
Handbook Editors
|
| Other comments |
|
ipHandbook of Best Practices: Further Education and Degree Programs
|
0 |
Admin |
20 |
26/02/2010 05:00:39
Admin
|